Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$140.52 USD

140.52
1,215,852

+1.00 (0.72%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $140.66 +0.14 (0.10%) 6:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

Zacks Equity Research

DaVita (DVA) Ties Up with Cigna Arm, Expands in Los Angeles

by Zacks Equity Research

DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners, a unit within its medical group, has entered into a strategic partnership with Cigna, a global health insurance service company.

    Zacks Equity Research

    DaVita (DVA) Earnings Beat Estimates, Revenues Lag in Q4

    by Zacks Equity Research

    DaVita Inc. (DVA) reported fourth-quarter 2016 adjusted operating earnings of 98 cents per share that surpassed the Zacks Consensus Estimate of 91 cents.

      Zacks Equity Research

      ITT Inc. (ITT) Q4 Earnings: What's in Store for the Stock?

      by Zacks Equity Research

      ITT Inc. (ITT) is slated to report fourth-quarter 2016 results before the opening bell on Feb 14.

        Zacks Equity Research

        Can Allscripts (MDRX) Surprise Investors in Q4 Earnings?

        by Zacks Equity Research

        Allscripts Healthcare Solutions Inc. (MDRX) is scheduled to release fourth-quarter 2016 results on Feb 16.

          Zacks Equity Research

          Can Nutrisystem (NTRI) Surprise Investors in Q4 Earnings?

          by Zacks Equity Research

          Nutrisystem Inc. (NTRI) is scheduled to release fourth-quarter 2016 results on Feb 27.

            Zacks Equity Research

            Ecolab (ECL): What's in the Cards this Earnings Season?

            by Zacks Equity Research

            St. Paul, MN-based Ecolab Inc. (ECL), a leading provider of water, hygiene and energy technologies and services, is expected to report fourth-quarter 2016 results on Feb 21.

              Zacks Equity Research

              DENTSPLY (XRAY) Q4 Earnings: Is Disappointment in Store?

              by Zacks Equity Research

              York, PA-based DENTSPLY Sirona Inc. (XRAY), a dental solutions company, is expected to report fourth-quarter 2016 results on Feb 10.

                Zacks Equity Research

                Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?

                by Zacks Equity Research

                DaVita HealthCare Partners Inc. (DVA) is set to report fourth-quarter 2016 results after market close on Feb 9.

                  Zacks Equity Research

                  Why Earnings Season Could Be Great for DaVita (DVA)

                  by Zacks Equity Research

                  DaVita (DVA) looks like an exciting pick for investors as it is poised to beat at earnings season.

                    Zacks Equity Research

                    4 Healthcare Players Likey to Trump Q4 Earnings Estimates

                    by Zacks Equity Research

                    Trump's victory has sent waves across the Healthcare industry.

                      Zacks Equity Research

                      Cerner (CERN): What's in the Cards this Earnings Season?

                      by Zacks Equity Research

                      Cerner Corporation (CERN), a leading global provider of healthcare information technology solutions ("HCIT"), is set to report fourth-quarter 2016 results, after the closing bell on Feb 9.

                        Zacks Equity Research

                        Cardinal Health (CAH) Q2 Earnings: What's in the Cards?

                        by Zacks Equity Research

                        Cardinal Health (CAH), a global player in the healthcare services and products space, is set to report second-quarter fiscal 2017 results on Feb 7, before the bell.

                          Zacks Equity Research

                          Pacific Biosciences (PACB): What Awaits in Q4 Earnings?

                          by Zacks Equity Research

                          Pacific Biosciences of California Inc. (PACB) is scheduled to report fourth-quarter 2016 results on Feb 1, 2017.

                            Zacks Equity Research

                            Varian Medical (VAR) Q1 Earnings: Is a Surprise in Store?

                            by Zacks Equity Research

                            Varian Medical Systems Inc. (VAR) is set to report results for the first quarter of fiscal 2017 on Jan 25, after the closing bell.

                              Zacks Equity Research

                              Is Earnings Beat Likely for Intuitive Surgical (ISRG) in Q4?

                              by Zacks Equity Research

                              We expect Intuitive Surgical Inc (ISRG) to beat earnings expectations when it reports fourth-quarter 2016 and full-year results on Jan 24.

                                Zacks Equity Research

                                Stryker (SYK): Can It Post a Beat this Earnings Season?

                                by Zacks Equity Research

                                Delving deeper into the fundamentals of Stryker Corporation (SYK), we expect the stock to beat earnings estimates this quarter.

                                  Zacks Equity Research

                                  DaVita Ties Up With WellHealth, Expands in Southern Nevada

                                  by Zacks Equity Research

                                  DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.

                                    Zacks Equity Research

                                    DaVita Ties Up With Inspira Health, Expands in South Jersey

                                    by Zacks Equity Research

                                    DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services in the U.S., announced a joint venture with Inspira Health Network to expand dialysis services at the Bridgeton, Millville and Vineland centers of South Jersey.

                                      Kevin Cook headshot

                                      Bear of the Day: DaVita HealthCare Partners (DVA)

                                      by Kevin Cook

                                      Shifting winds in Medicare and ACA exchanges clipped shares 18% in August. Are the lows in on this upgrade?

                                        Kevin Cook headshot

                                        Bear of the Day: DaVita HealthCare Partners (DVA)

                                        by Kevin Cook

                                        Analysts saw this one coming and pushed the Zacks Rank down before a 13% drop since earnings